Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: Assessment of Lung Function After Single Inhalations of a Bronchodilator From 2 Configurations a Dry Powder Inhaler. [Phase 1]
Phase 1 study assessing acute lung function after single inhalations of a bronchodilator delivered via two dry powder inhaler configurations…
-
CLINICAL_TRIALS trial_result · 2017-06-15Clinical Trial Update: A Study to Assess the Bioavailability and to Compare the Pharmacokinetics of AZD7594 Inhaled Via Monodose Inhaler and Multiple-dose Dry Powder Inhalers (DPI) or Pressurized Metered-dose Inhaler (pMDI) in Healthy Male Subjects [Phase 1]
Phase 1 study evaluating bioavailability and pharmacokinetics of AZD7594 inhaled via different devices in healthy male subjects; results pos…
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Changes in Cardiac Function in COPD Patients After Administration of Budesonide/Formoterol (Symbicort®) Versus Placebo [Phase 4]
Phase 4 trial evaluating cardiac function in COPD patients treated with budesonide/formoterol (Symbicort) versus placebo. The study was term…
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Pharmacokinetic and Safety of GSK573719 and GW642444 Administered Individually and Concurrently, With Verapamilin in Healthy Subjects [Phase 1]
Phase 1 pharmacokinetic and safety study of GSK573719 and GW642444 administered alone and with verapamil in healthy subjects.
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: The Safety and Efficiency of Sildenafil in the Treatment of Severe Post-capillary Pulmonary Hypertension Caused by COPD [NA]
This document is a clinical trial update examining the safety and efficacy of sildenafil for severe post-capillary pulmonary hypertension ca…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: First Time in Human Study With GSK1325756 [Phase 1]
First-time-in-human Phase 1 study of the investigational compound GSK1325756 by GlaxoSmithKline in chronic obstructive pulmonary disease has…
-
CLINICAL_TRIALS trial_result · 2017-06-12Clinical Trial Update: Efficacy and Safety of AQX-1125 in Unstable COPD [Phase 2]
Phase 2 study of AQX-1125 in unstable COPD completed with reported efficacy and safety results. Results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-06-12Clinical Trial Update: Comparing the Efficacy of Symbicort® pMDI and Formoterol Turbuhaler in Reducing Exacerbations in Patients With Cronic Obstructive Pulmonary Disease [Phase 3]
This Phase 3 trial compared Symbicort pMDI with Formoterol Turbuhaler in COPD patients to determine exacerbation reduction. Results were pos…
-
CLINICAL_TRIALS trial_result · 2017-06-12Clinical Trial Update: Study to Evaluate the Safety of Long-Term Use of Perforomist® (Formoterol Fumarate) [Phase 4]
A Phase 4 study, sponsored by Dey, evaluating the long-term safety of Perforomist (formoterol fumarate) in chronic obstructive pulmonary dis…
-
CLINICAL_TRIALS trial_result · 2017-06-12Clinical Trial Update: QTc Study GSK573719+GW642444 [Phase 1]
A completed Phase 1 clinical trial update. The study evaluated the QTc effects of two GSK compounds, GSK573719 and GW642444, in patients wit…
-
CLINICAL_TRIALS trial_result · 2017-06-12Clinical Trial Update: A Study to Look at How GSK1325756 is Taken up by the Body When Given by Mouth When Stomach Acid is Reduced [Phase 1]
A Phase 1 study evaluating the oral absorption of GSK1325756 under reduced stomach acid conditions has completed.
-
CLINICAL_TRIALS trial_result · 2017-06-08Clinical Trial Update: PT001 MDI Versus Atrovent Study in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
A Phase 2 trial comparing PT001 MDI to Atrovent in moderate-to-severe chronic obstructive pulmonary disease has completed and posted results…
-
CLINICAL_TRIALS trial_result · 2017-06-07Clinical Trial Update: Pharmacokinetics Of Umeclidinium and Vilanterol in Healthy Chinese, a Randomized, Open Label, 3 Crossover Study. [Phase 1]
A randomized, open-label, three-crossover Phase 1 study assessing the pharmacokinetics of umeclidinium and vilanterol in healthy Chinese vol…
-
CLINICAL_TRIALS trial_result · 2017-06-06Clinical Trial Update: A Study to Evaluate the Effect of the Combination of Umeclidinium (UMEC) and Vilanterol (VI) on Exercise Endurance Time (EET) in Participants With Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]
Phase 4 trial assessing the combination of umeclidinium and vilanterol on exercise endurance in COPD was completed with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2017-06-05Clinical Trial Update: Number of Multiple Breath Washout Tests in Adults With Pulmonary Disease and Healthy Controls
Completed clinical trial update on the number of multiple breath washout tests performed in adults with pulmonary disease and healthy contro…
-
CLINICAL_TRIALS trial_result · 2017-06-01Clinical Trial Update: ENOSE in Pulmonary Tuberculosis in Yogyakarta [NA]
The ENOSE trial investigating pulmonary tuberculosis and related COPD conditions in Yogyakarta has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Muscular Training-induced Changes in COPD [NA]
This entry reports a completed clinical trial investigating the effects of muscular training on individuals with chronic obstructive pulmona…
-
CLINICAL_TRIALS trial_result · 2017-05-25Clinical Trial Update: Effect of Supplementary Vitamins on Oxidant Gene Expression in the Lungs of Healthy Smokers [NA]
A completed clinical trial evaluating whether supplementary vitamins influence oxidant gene expression in the lungs of healthy smokers.
-
CLINICAL_TRIALS trial_result · 2017-05-23Clinical Trial Update: Endobronchial Valves in Moderate COPD [NA]
A completed clinical trial evaluated endobronchial valves in patients with moderate chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2017-05-22Clinical Trial Update: Risk of Re-Hospitalization in Patients With Chronic Obstructive Pulmonary Disease (COPD) Post Exacerbation
This document provides an update on a completed GlaxoSmithKline-sponsored trial examining the risk of hospital readmission in patients with …
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Broccoli Sprout Extracts Trial to See if NRF2 is Enhanced by Sulforaphane Treatment in Patients With COPD [Phase 2]
A Phase 2 study investigated whether sulforaphane from broccoli sprout extracts can enhance NRF2 activity in patients with COPD; the trial i…
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Behavioral Intervention to Maintain Physical Capacity and Activity in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
Phase 2 clinical trial update on a behavioral intervention to maintain physical capacity and activity in Chronic Obstructive Pulmonary Disea…
-
CLINICAL_TRIALS trial_result · 2017-05-18Clinical Trial Update: Investigation of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of Oral Danirixin in Symptomatic COPD Subjects With Mild to Moderate Airflow Limitation at Risk for Exacerbations [Phase 2]
A Phase 2 study evaluating safety, tolerability, pharmacokinetics, pharmacodynamics, and clinical efficacy of oral danirixin in adults with …
-
CLINICAL_TRIALS trial_result · 2017-05-18Clinical Trial Update: Effects of Combined Cycle Training and Inspiratory Muscle Training in Patients With COPD [NA]
Update on a completed clinical trial evaluating the effects of combined cycle training and inspiratory muscle training in patients with COPD…
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Altitude Related Illness In Patients With Respiratory Disease [Phase 4]
Phase 4 clinical trial evaluating altitude-related illness in patients with chronic obstructive pulmonary disease has completed.